Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.

Name: Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.
License: Public Domain

Memorial Sloan Kettering Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 287552
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.